Loading content...
Loading comments...
CEFIXIME
Wed Sep 04 2024
Reason for Recall
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
Manufacturers
| Drug | Manufacturer |
|---|---|
| CEFIXIME | Lupin Pharmaceuticals, Inc. |
Number of affected units
4554 bottles
Distribution pattern
USA nationwide.
UPCs
| UPC |
|---|
| 0368180423119 |
| 0368180416081 |
| 0368180423089 |
| 0368180416111 |
| 0368180407041 |
Package NDCs
| NDC |
|---|
| 68180-405-01 |
| 68180-407-03 |
| 68180-407-04 |
| 68180-416-11 |
| 68180-416-08 |
| 68180-423-11 |
| 68180-423-08 |
Comments (-)
Must be signed in to post a comment.
No comments.